Latest Articles
Team angelMD • July 24, 2017

For this week’s #StartupSpotlight, we take a look at Medifies, a company building a platform that helps healthcare providers give updates to families while maintaining HIPAA compliance. We spoke with CEO Nate Pagel, to learn about Medifies. To find out more about Medifies, check out their angelMD profile. Please provide a short overview of your ...
Read more

LinkedInTwitterFacebook
Team angelMD • July 21, 2017

The Friday Roundup is a collection of five stories that you need to know about each week. From policy, to innovations, look to us to keep you up to date on what’s happening in the healthcare industry.   Cleveland Clinic Struggles to Connect with Local Community   An $8 billion health system should have impact ...
Read more

LinkedInTwitterFacebook
Ben Philips • July 20, 2017

Private equity is an asset class that involves buying stake in companies that are not publicly traded. It is generally purchased through a private equity firm, a venture capital firm, or an angel investor. Investing in the right company in its infancy can be extremely lucrative but knowing about private equity is essential in this ...
Read more

LinkedInTwitterFacebook
Team angelMD • July 18, 2017

As Michelle Faits discussed earlier in an angelMD #StartupSpotlight, Pro-Arc Diagnostics makes a blood test to detect mutated forms of the JC virus (JCV) which may increase one’s risk of developing Progressive Multifocal Leukoencephalopathy (PML), an often fatal disease. What is PML? Approximately 75-80% of humans are infected by the JC virus, a polyomavirus which ...
Read more

LinkedInTwitterFacebook
Brendan Long • July 17, 2017

For this week’s #StartupSpotlight, we take a look at Batu Biologics, a company with a novel approach to cancer treatment. Innovating Treatment Batu Biologics is an immuno-oncology company focused on the development and commercialization of therapies that target the Achilles heel of cancer: tumor blood vessels.  They operate under the belief that the most powerful ...
Read more

LinkedInTwitterFacebook